Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Total Assets 2019–2025
Allogene Therapeutics Inc. annual total assets history from 2019 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Allogene Therapeutics Inc. total assets as of December 31, 2025: 415.9M, a 24.20% decrease year-over-year.
- Allogene Therapeutics Inc. total assets for 2025 were 415.9M, a 24.20% decrease from 2024.
- Allogene Therapeutics Inc. total assets for 2024 were 548.7M, a 14.64% decrease from 2023.
- Allogene Therapeutics Inc. total assets for 2023 were 642.8M, a 21.76% decrease from 2022.
- Allogene Therapeutics Inc. total assets for 2022 were 821.6M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Allogene Therapeutics Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $416 |
| 2024 | $549 |
| 2023 | $643 |
| 2022 | $822 |
| 2021 | $1,051 |
| 2020 | $1,228 |
| 2019 | $718 |
Allogene Therapeutics Inc. Total Assets — FAQ
Allogene Therapeutics Inc. (ALLO) total assets over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's total assets history?
The chart and table above show Allogene Therapeutics Inc.'s total assets by year and by quarter, including the growth rate.